Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
10	7	Search

2025	ACT001 Inhibits Tumor Progression and Modulates Immune Responses in Non‐Small Cell Lung Cancer Journal of Clinical Laboratory Analysis Zhijing Shi, Yiman Li, Huijie Hou, Zhitao Wang, Hui Guo, Yang Yu, Yan Song, Zhe Chen
2024	Immune Cytolytic Activity and Strategies for Therapeutic Treatment International Journal of Molecular Sciences Stephanie Agioti, Apostolos Zaravinos
2022	Springer Handbooks of Computational Statistics Xiaoqing Yu
2021	Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study Cancer Immunology, Immunotherapy Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Cheng Xiao, Huan Wang, Lisong Teng, Hui Zhou, Shuyan Wang, Donglei Zhu, Tao Sun, Yingying Yu, Wenying Guo, Nong Xu
2021	Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma Frontiers in Oncology Ang Li, Hongjiao Wu, Qinqin Tian, Yi Zhang, Zhi Zhang, Xuemei Zhang
2021	Genetic and immunologic features of recurrent stage I lung adenocarcinoma Scientific Reports Johannes R. Kratz, Jack Z. Li, Jessica Tsui, Jen C. Lee, Vivianne W. Ding, Arjun A. Rao, Michael J. Mann, Vincent Chan, Alexis J. Combes, Matthew F. Krummel, David M. Jablons
2020	Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma PeerJ Xiaoguang Qi, Chunyan Qi, Xindan Kang, Yi Hu, Weidong Han
2020	Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene‐expression–based retrospective study Journal of Cellular Biochemistry Genwen Chen, Zhongyi Dong, Dehua Wu, Yuhan Chen
	Additional cited-by details will be shown when available from Crossref